Trial · NCT00002597
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival Rate (10-year) | Hormone Therapy + Radiation Therapy | 61.9 | 95% Confidence Interval 58.3 to 65.3 | percentage of patients | |
| Overall Survival Rate (10-year) | Radiation Therapy Alone | 56.8 | 95% Confidence Interval 53.2 to 60.2 | percentage of patients | |
| Disease-specific Survival Rate (10 Years) | Hormone Therapy + Radiation Therapy | 95.7 | 95% Confidence Interval 94.3 to 97.2 | percentage of participants | |
| Disease-specific Survival Rate (10 Years) | Radiation Therapy Alone | 92.6 | 95% Confidence Interval 90.8 to 94.4 | percentage of participants | |
| Local Progression Rate (10 Years) | Hormone Therapy + Radiation Therapy | 10.9 | 95% Confidence Interval 8.8 to 12.9 | percentage of participants | |
| Local Progression Rate (10 Years) | Radiation Therapy Alone | 16.1 | 95% Confidence Interval 13.7 to 18.4 | percentage of participants | |
| Distant Failure Rate (10 Years) | Hormone Therapy + Radiation Therapy | 5.5 | 95% Confidence Interval 3.9 to 7.0 | percentage of participants | |
| Distant Failure Rate (10 Years) | Radiation Therapy Alone | 8.0 | 95% Confidence Interval 6.2 to 9.8 | percentage of participants | |
| Biochemical Failure Rate (10 Years) | Hormone Therapy + Radiation Therapy | 26.3 | 95% Confidence Interval 23.4 to 29.2 | percentage of participants | |
| Biochemical Failure Rate (10 Years) | Radiation Therapy Alone | 41.1 | 95% Confidence Interval 37.9 to 44.4 | percentage of participants | |
| Clinical Relapse Rate (10 Years) | Hormone Therapy + Radiation Therapy | 15.0 | 95% Confidence Interval 12.6 to 17.3 | percentage of participants | |
| Clinical Relapse Rate (10 Years) | Radiation Therapy Alone | 21.7 | 95% Confidence Interval 19.1 to 24.4 | percentage of participants | |
| Second Biochemical Relapse Rate (10 Years) | Hormone Therapy + Radiation Therapy | 2.7 | 95% Confidence Interval 1.6 to 3.8 | percentage of participants | |
| Second Biochemical Relapse Rate (10 Years) | Radiation Therapy Alone | 6.1 | 95% Confidence Interval 4.4 to 7.7 | percentage of participants | |
| Disease-free Survival Rate (10 Years) | Hormone Therapy + Radiation Therapy | 51.7 | 95% Confidence Interval 48.1 to 55.1 | percentage of participants | |
| Disease-free Survival Rate (10 Years) | Radiation Therapy Alone | 39.5 | 95% Confidence Interval 36.1 to 42.9 | percentage of participants | |
| Positive Re-biopsy Rate at Two Years | Hormone Therapy + Radiation Therapy | 20.2 | percentage of participants | ||
| Positive Re-biopsy Rate at Two Years | Radiation Therapy Alone | 38.9 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00002597/results